BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 16607831)

  • 1. [Differentiated thyroid cancer--staging and prognostic systems].
    Dănilă R; Andriescu L; Grigorovici A; Dragomir C; Găluşcă B; Vulpoi C; Ungureanu C; Mogoş V
    Rev Med Chir Soc Med Nat Iasi; 2005; 109(1):71-6. PubMed ID: 16607831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.
    Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB
    Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prospective therapy study in differentiated thyroid carcinoma].
    Gemsenjäger E; Heitz P; Martina B
    Schweiz Med Wochenschr; 1995 Nov; 125(46):2226-36. PubMed ID: 8525342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapy concept in differentiated thyroid gland carcinoma--results of 25 years with 257 patients].
    Gemsenjäger E; Heitz PU; Martina B; Schweizer I
    Praxis (Bern 1994); 2000 Nov; 89(44):1779-97. PubMed ID: 11109916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiated thyroid cancer: role of the lymph node dissection.
    Caglià P; Zappulla E; Costa S; Tracia M; Veroux M; Russo V; Borzì L; Lucifora B; Patanè G; Tracia L; Amodeo C
    G Chir; 2010; 31(6-7):293-5. PubMed ID: 20646374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of lymphadenectomy in the treatment of differentiated thyroid cancer].
    Dănilă R; Popovici R; Andriescu L; Timofte D; Ungureanu MC; Găluşcă B; Dragomir C
    Rev Med Chir Soc Med Nat Iasi; 2007; 111(1):129-34. PubMed ID: 17595858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of total thyroidectomy in the management of differentiated thyroid cancer.
    Stephenson BM; Wheeler MH; Clark OH
    Curr Opin Gen Surg; 1994; ():53-9. PubMed ID: 7584009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multifactorial analysis of survival and recurrences in differentiated thyroid cancer. Comparative evaluation of usefulness of AGES, MACIS, and risk group scores in Mexican population.
    Rodríguez-Cuevas S; Labastida-Almendaro S; Cortés-Arroyo H; López-Garza J; Barroso-Bravo S
    J Exp Clin Cancer Res; 2002 Mar; 21(1):79-86. PubMed ID: 12071534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AMES, MACIS and TNM prognostic classifications in papillary thyroid carcinoma.
    Voutilainen PE; Siironen P; Franssila KO; Sivula A; Haapiainen RK; Haglund CH
    Anticancer Res; 2003; 23(5b):4283-8. PubMed ID: 14666639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Significance of lymph node metastases of differentiated thyroid gland carcinomas and C-cell carcinomas for prognosis--a meta-analysis].
    Witte J; Schlotmann U; Simon D; Dotzenrath C; Ohmann C; Goretzki PE
    Zentralbl Chir; 1997; 122(4):259-65. PubMed ID: 9221636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis, treatment, prognostic factors and long-term outcome in papillary thyroid carcinoma.
    Pelizzo MR; Merante Boschin I; Toniato A; Pagetta C; Casal Ide E; Mian C; Rubello D
    Minerva Endocrinol; 2008 Dec; 33(4):359-79. PubMed ID: 18923371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study.
    Lundgren CI; Hall P; Dickman PW; Zedenius J
    Cancer; 2006 Feb; 106(3):524-31. PubMed ID: 16369995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lymphadenectomy in differentiated thyroid carcinoma].
    Varaldo E; Ansaldo GL; Puglisi M; Pennati S; Torre GC
    G Chir; 2010; 31(6-7):273-6. PubMed ID: 20646368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical management of cervical lymph nodes in differentiated thyroid cancer.
    Fritze D; Doherty GM
    Otolaryngol Clin North Am; 2010 Apr; 43(2):285-300, viii. PubMed ID: 20510715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controversies in the surgical management of differentiated thyroid carcinoma.
    Noguchi M; Katev N; Miyazaki I
    Int Surg; 1996; 81(2):163-7. PubMed ID: 8912084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implications of prognostic factors and risk groups in the management of differentiated thyroid cancer.
    Shaha AR
    Laryngoscope; 2004 Mar; 114(3):393-402. PubMed ID: 15091208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Multifactorial prognostic analysis in the surgical treatment of well differentiated thyroid neoplasms].
    Zani B; Tirone G; Valduga P; Silvestri M; Eccher C
    Minerva Chir; 2002 Aug; 57(4):475-9. PubMed ID: 12145578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiated thyroid cancer in a Swedish county--long-term results and quality of life.
    Malterling RR; Andersson RE; Falkmer S; Falkmer U; Niléhn E; Järhult J
    Acta Oncol; 2010 May; 49(4):454-9. PubMed ID: 20092427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Papillary and follicular variant of papillary carcinoma of the thyroid: Initial presentation and response to therapy.
    Burningham AR; Krishnan J; Davidson BJ; Ringel MD; Burman KD
    Otolaryngol Head Neck Surg; 2005 Jun; 132(6):840-4. PubMed ID: 15944551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors in well-differentiated thyroid carcinoma in patients treated and followed in the same institution.
    Cappelli C; Pirola I; Braga M; De Martino E; Morassi ML; Gandossi E; Mattanza C; Balzano R; Castellano M; Rosei EA
    Ann Ital Chir; 2006; 77(2):107-13. PubMed ID: 17147082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.